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Abstract: We describe a quickly alternating pattern of anterior
tibialis activation, recorded during nocturnal polysomnography
in 16 patients. Polysomnography, usually for sleep-disordered
breathing, included surface electromyograms over the anterior
tibialis of each leg. Cases were identified from approximately
1,500 studies reviewed in the course of standard clinical care.
Patients were 12 men and 4 women (mean age, 41  15 years;
range, 12–70 years). Brief activation of the anterior tibialis in
one leg alternated with similar activation in the other leg.
Activations occurred at a frequency of approximately 1 to 2 Hz,
each lasted between 0.1 and 0.5 seconds, and sequences of
alternating activations usually lasted between several and 20
seconds. The phenomenon occurred in all sleep stages but
particularly during arousals. Ten of the 16 patients had periodic
leg movements during sleep at a rate  5.0 per hour, and 12 of
the 16 patients were taking antidepressant medication. Alter-
nating leg muscle activation (ALMA) during sleep, at this
relatively high frequency, may be a newly described phenom-
enon. We speculate that ALMA could represent transient fa-
cilitation of a spinal central pattern generator for locomotion,
perhaps due to serotonergic effects of antidepressant medica-
tion. © 2003 Movement Disorder Society
Key words: sleep; nocturnal myoclonus syndrome; seroto-
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Surface electromyography of the anterior tibialis is
commonly performed during polysomnography, mainly
to record periodic leg movements during sleep
(PLMS).1,2 The PLMS can occur on one side or the other
at different times of the night, and sometimes simulta-
neously on both sides but at different rates.3 Recent
detailed investigation of 10 patients showed that some-
times PLMS alternate sides.4 Involvement of upper limbs
in some patients has led some authors to speculate that
PLMS are spinal fragments of a locomotor pattern, per-
haps dysinhibited by supraspinal mechanisms,5 but
PLMS are typically separated by 20- to 40-second inter-
vals that are much longer than those between leg move-
ments during ambulation.
We describe a sleep-related pattern of alternating leg
muscle activation (ALMA) that approximates, in fre-
quency, that seen in human locomotion. Most of the 16
patients who demonstrated ALMA were studied for ob-
structive sleep apnea, but most also proved to have
PLMS, and most also took antidepressant medication.
SUBJECTS AND METHODS
Subjects
Subjects were referred to the sleep laboratory and
studied between February of 2000 and August of 2001.
The 16 index cases of ALMA included in this report
were identified from an estimated 1,500 polysomno-
grams that were reviewed by the authors during the given
time period as part of their routine clinical work. After
identification of the first case, the search for additional
examples was informal, and some cases may have been
missed. Data were obtained from sleep studies, referrals,
sleep clinic notes, and technician intakes that on the night
of polysomnography recorded current medications. Data
were examined, correlates identified, and etiological hy-
potheses generated only after the entire series had been
assembled. In addition, medication regimens of identi-
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fied cases were compared to those of 100 patients within
the same age range who were referred to the sleep
laboratory during the same period. These 100 subjects
were the first 10 to be studied in each of 10 consecutive
months between October of 2000 and July of 2001.
The mean age of the index subjects was 41  15 (SD)
years, and 12 (75%) were men (Table 1). Twelve had
been referred for evaluation of sleep-disordered breath-
ing or for continuous positive airway pressure (CPAP)
titration to identify an effective setting for home use. One
subject had been referred for assessment of each of the
following: possible narcolepsy, PLMS, sleepwalking,
and movement during sleep in the context of Hunting-
ton’s disease. Nine subjects complained of excessive
daytime sleepiness or fatigue, and 7 had Epworth Sleep-
iness Scale scores that were greater than 10.6 Clinic or
lab notes showed complaints of insomnia in 2 subjects.
Four subjects had a complaint of restless legs or more
general restlessness at night, but none had a bed partner
who had mentioned involuntary leg kicking. One subject
complained of sudden nocturnal muscle contractions in
the legs and the sensation that his legs were vibrating.
Of the 16 subjects, 10 had had a history and physical
examination performed by a board-certified or eligible
neurologist, 2 by neurosurgeons, 2 by internists, and 1 by
a physician’s assistant. No recorded examination was
TABLE 1. Demographics, polysomnography results, medications, and sleep stage in which
alternating leg muscle activation was observed
Age (yr) Sex Study type Dx PLMI AHI mO2 Antidepressant Other medications Stage
21 F Diagnostic PLMS 27.3 7.7 93 Paroxetine 2
38 F Titration OSA 17.9 Bupropion Methylphenidate,
levothyroxin
1, 2, REM
14 F Diagnostic PLMS 15.5 0.4 95 Imipramine,
trazodone
Buspirone 2, 3, REM
12 M Diagnostic PLMS,
enuresis
2.2 1.2 94 Fluoxetine Montelukast, prednisone,
inhaler
1, 2, REM






37 M Diagnostic OSA, PLMS 13.8 10.4 90 Bupropion Atorvastatin 1, 2
57 M Diagnostic OSA,
bruxism




vitamin C, vitamin E
1, 2, REM
48 M Diagnostic PLMS, OSA 25.0 9.9 91 Citalopram Methylphenidate,
diazepam
1
36 M Split night OSA 3.5 10.8 82 Venlafaxine Dextroamphetamine &
racemic amphetamine
1, 2, REM
46 M Diagnostic PLMS 26.4 1.9 91 Paroxetine Sildenafil prn 2
44 M Diagnostic OSA, PLMS 53.2 7.9 86 None Phenobarbital, phenytoin,
aspirin, loratadine
REM













44 M Titration OSA 8.1 None Ibuprofen 1
44 M Titration OSA 0.0 None None 1, REM
53 M Titration OSA, PLMS 122.8 Fluoxetine Celecoxib, pramipexole,
ibuprofen
1, 2





PLMI, periodic leg movement index; AHI, apnea hypopnea index (for diagnostic studies only); mO2, minimum oxygen saturation (for diagnostic
studies only); Stage, sleep stages (i.e., other than wakefulness) from which ALMA were observed to emerge; Diagnostic, baseline sleep study, without
intervention; Titration, titration study to determine appropriate setting for continuous positive airway pressure (CPAP); Split Night, study in which
the first portion of the night was a diagnostic study and the second portion was used for CPAP titration; OSA, obstructive sleep apnea; PLMS, periodic
leg movements during sleep; REM, rapid eye movement sleep; 1, 2, and 3: non-REM sleep stages 1, 2, and 3/4, respectively.
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available for 1 index subject. Aside from the patient with
Huntington’s disease, none of the remaining 14 patients
with history and physical data had a history of Parkin-
son’s disease, and none were noted to have the resting
tremor, bradykinesia, rigidity, or postural instability that
characterize this condition.
All subjects except for 3 had an apnea/hypopnea index
(AHI, number of events per hour of sleep) 5 on the
current or previous diagnostic study. The periodic leg
movement index (PLMI) was 5 in 10 (63%) of the
index studies; only 2 patients had no scored PLMS. Two
patients without PLMI 5 had many hypopneas and
arousals associated with leg movements that would have
counted as PLMS had hypopneas not been scored. Four
patients met criteria for restless legs syndrome; 10 did
not, and 2 did not have sufficient information available to
make this determination adequately.7 No subject demon-
strated epileptiform activity on the limited electroen-
cephalogram (EEG) included in the polysomnographic
montage. Demographics, diagnoses at the time that poly-
somnograms were interpreted, PLMI, AHI, minimum
oxygen saturation, antidepressants taken at the time of
the study, and other medications are listed in Table 1.
Twelve of the 16 index patients (75%) were taking
antidepressants at the time of polysomnography. In con-
trast, among the 100 comparison subjects referred for
polysomnography during a similar time interval, only 22
(22%) were taking antidepressants. Listed reasons for
antidepressants among the index cases were depression
(n  7), bipolar disorder (n  1), anxiety disorder (n 
1), smoking cessation (n  1), attention-deficit/hyperac-
tivity disorder (n 1), and behavioral control in the
patient with Huntington’s disease (n  1).
Polysomnography
Polysomnograms included two central and two occip-
ital EEG leads, chin surface electromyogram (EMG),
two electro-oculogram (EOG) leads, left and right ante-
rior tibialis surface EMG leads, two electrocardiogram
(EKG) leads, nasal and oral airflow (thermocouples in
diagnostic studies, nasal and oral pressure in titration
studies), chest and abdominal excursion (piezoelectric
strain gauges), and oximetry. Among the 16 index stud-
ies that came to the authors’ attention, nine recordings
were made for diagnostic purposes, six were made dur-
ing continuous positive airway pressure (CPAP) titration
studies, and one was a split-night study in which the first
portion was diagnostic and the second was used to titrate
CPAP.
Records were scored by experienced technicians who
had scored at least 90% of a set of validity studies
correctly. Apneas were defined as 10 seconds of absent
airflow. Hypopneas were scored as 10-second decre-
ments in airflow, chest, or abdominal movement fol-
lowed by an arousal, awakening, or oxygen desaturation
of four or more percentage points. The PLMS were
scored when they met criteria for duration (0.5 to 5
seconds), periodicity (5 to 120 seconds between each
movement), and number (three or more in a row). When
a hypopnea occurred between two anterior tibialis acti-
vations that would otherwise qualify to be scored as




The ALMA pattern was observed in each subject,
usually several times in each recording (Fig. 1). Defined
as more than four discrete and alternating muscle acti-
vations with 2 seconds between activations, the num-
ber of ALMA sequences during sleep per record ranged
from 1 to 40 (mean  SD, 13  12). Each sequence of
ALMA during sleep lasted for 1.4 to 22.2 seconds, and
each was composed of alternating anterior tibialis acti-
vations of approximately 0.1 to 0.5 seconds in length.
These sequences sometimes began with one to several
lengthy activations (1–2 seconds) in one or both legs.
The rate of leg activation was usually between 1 and 2
Hz, but ranged from 0.5 to 3.0 Hz. Some patients showed
similar activity in one leg, at times, rather than two (Fig.
2A).
In 12 subjects, ALMA was seen to closely precede or
follow an arousal or awakening and to gradually dimin-
ish as the patient returned to sleep (Fig. 3). However, the
phenomenon was seen without arousals in 4 subjects.
With or without arousals, ALMA was observed to arise
from non–rapid eye movement (non-REM) sleep stages
1, 2, 3, and 4, and from REM sleep. Leg muscle activa-
tions during REM sleep (Fig. 2B) were often briefer and
somewhat less regular than during non-REM sleep (Fig.
2A), but could still be distinguished from the irregular,
nonalternating phasic twitches that normally characterize
REM sleep (Fig. 2C). When arousals did occur, they
were usually observed to start before ALMA (n  7
subjects). In 2 subjects, arousals came either before or
after ALMA, and in 3 subjects, arousals consistently
followed the onset of ALMA.
In some cases, 5- to 10-second sequences of ALMA
recurred at intervals that resembled those between PLMS
(e.g., 20–30 seconds). However, sequences of ALMA
also occurred just before, just after, or occasionally dis-
tinctly between PLMS without any obvious tendency to
reset the periodicity of the PLMS. In 1 subject, a record-
ALTERNATING LEG ACTIVATION DURING SLEEP 553
Movement Disorders, Vol. 18, No. 5, 2003
ing of extensor forearm muscle surface EMG was also
performed. The results suggested some upper extremity
alternating activity in association with ALMA, although
less clearly defined than the lower extremity phenome-
non (Fig. 4).
Repeat Recordings
The index studies that demonstrated ALMA were col-
lected during a 19-month period, during which less than
half of the laboratory’s studies were reviewed by the
authors. Among the 9 patients who had diagnostic index
studies, 3 later had CPAP titration studies, and review of
these studies showed ALMA in 2. Among the 6 patients
whose index studies were CPAP titrations, all 6 had had
diagnostic studies in the same laboratory, and each of
these diagnostic studies also showed ALMA. For the 9
subjects who had both diagnostic and CPAP titration
studies, the mean number of ALMA sequences in the
diagnostic studies was 14, and that in the titration studies
was also 14. The relationship between the timing of
arousals and ALMA was also preserved between studies.
Among patients who had a repeat recording, the 1 patient
whose ALMA preceded arousals in the index study
showed the same pattern during the repeat study, and the
5 in whom ALMA followed arousals also showed the
same pattern in the repeat studies.
DISCUSSION
We describe a previously unreported pattern of alter-
nating leg muscle activation, at a rate of approximately 1
FIG. 1. Sequences of alternating leg muscle activation (ALMA) in a 53-year-old woman, during arousals from this 60-second segment of stage 1
sleep. LOC-A2, ROC-A2  left and right electro-oculogram, respectively; Chin3–Chin2  chin surface electromyogram; C3-A2, C4-A1, O1-A2,
O2-A1  central and occipital derivations of international 10-20 electrode placement system; LAT1–LAT2, RAT1–RAT2  left and right anterior
tibialis surface electromyogram; EKG1–EKG2, A1-LAT1  two electrocardiogram leads; mflo  mask airflow during continuous positive airway
pressure titration study; oral1–oral2  oral leak as revealed by thermocouple; THOR2–THOR1  thoracic excursion; MID2–MID1  abdominal
excursion; sao2  oxygen saturation (%).
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to 2 Hz, during sleep or arousals from sleep. The
majority of the 16 patients with ALMA had obstruc-
tive sleep apnea, PLMS, and medication regimens that
included one or more antidepressants. The ALMA was
frequently associated with arousals, but also occurred in
every sleep stage. As discussed below, the ALMA could
represent any one of several previously reported motor
phenomena associated with sleep. Whether ALMA re-
flects a new, distinct motor phenomenon or an elabora-
tion of a previously defined entity, the question of why
its defining characteristic—regular alternation of activa-
tion from one leg to the other—has not been described
previously is not completely clear. The phenomenon may
be rare, and we may have identified it in part because our
laboratory performs a large volume of nocturnal studies.
Also, in contrast to some sleep laboratories, ours rou-
tinely records right and left leg movements indepen-
dently on two separate channels rather than one com-
bined channel.
The ALMA bears some resemblance to at least six
previously described phenomena. PLMS has been de-
scribed to occur in the form of polymyoclonus—bursts
of multiple jerks in frequencies not dissimilar to those of
ALMA—although not in an alternating side-to-side man-
ner and not in association with antidepressant medica-
tion.1,3 The frequency of PLMS in the current patient
series (63%) exceeds the already elevated frequency
(24%) among patients studied in our laboratory for sus-
pected sleep apnea.8 Against the hypothesis that ALMA
represents one form of PLMS, however, were several
examples where occurrence of ALMA in between clear
PLMS had no effect on the periodicity of the PLMS.
Furthermore, in contrast to ALMA, each leg activation in
PLMS lasts 0.5 to 5.0 seconds and the intervals between
movements are at least 4 seconds.
Montagna and colleagues described propriospinal my-
oclonus in 3 patients with severe insomnia.9 Features of
propriospinal myoclonus that resemble ALMA include
occurrence at transitions from wake to sleep, quasiperi-
odic intervals of 4 to 30 seconds between movements,
and a polyclonic composition of most movements. How-
ever, in contrast to ALMA, propriospinal myoclonus is
associated with severe insomnia, causes marked com-
plaints of involuntary jerking movements, occurs only
FIG. 2. Repeated sequences of alternating leg muscle activation (ALMA) in a 38-year-old woman (A,B). In A, some right leg activations are not
followed by left leg activations during 30 seconds of stage 1 non–rapid eye movement (non-REM) sleep. In B, activations are shorter and no associated
arousal occurs during 30 seconds of REM sleep. C: In contrast, a recording from a 36-year-old man without ALMA shows the irregular, nonalternating
pattern of muscle activity that normally characterizes REM sleep. Time scale and abbreviations as in Figure 1.
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during wakefulness, shows no reported tendency to al-
ternate between sides, and activates chin muscles (among
others) at the same time as the leg muscles.
The rhythmic movement disorder of sleep can occur at
rates up to 2 Hz, usually in wakefulness or light sleep but
rarely in other stages.1 The disorder can rarely involve
leg banging rather than the more common head banging
or body rocking, and in adults may be associated with
psychopathology. Rhythmic movement disorder is some-
times comorbid with PLMS, at least in patients with
severe restless legs syndrome, and some authors have
hypothesized that a similar pathophysiology may under-
lie all three conditions.10,11 However, rhythmic move-
ment disorder is most common in children, usually oc-
curs for many minutes rather than seconds, does not
involve alternating leg movements, and bears no known
relation to antidepressant medications.
In Parkinson’s disease resting tremor can affect the legs.
The tremor usually stops at sleep onset, but can recur for
brief intervals during arousals, light non-REM sleep, or
occasionally REM sleep. However, the tremor is usually
faster (3–5 Hz) than ALMA and has not been reported to
alternate sides. In addition, Parkinson’s disease usually be-
gins after age 50, whereas all but 4 of our 16 patients were
under 50 years of age. None of the patients in our series had
a known history of Parkinson’s disease or showed sugges-
tive signs on available neurological examinations.
Rhythmic leg movements have been described during
wakefulness in patients with neuroleptic-induced akathi-
sia.12–14 Electromyographic activity can be recorded at
the anterior tibialis at 0.5 to 3.0 Hz, for seconds to
minutes, but alternation between sides, occurrence dur-
ing sleep, and potential association with antidepressant
agents have not been described.
FIG. 3. An alternating leg muscle activation (ALMA) sequence that arose during an arousal and diminished as sleep returned to this 44-year-old man.
Time scale and abbreviations as in Figure 1; snore1-snore2  snoring monitor; ABD1-ABD2  abdominal excursion.
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Perhaps of greatest relevance, Broughton described a
hypnagogic foot tremor, in 2 patients who complained of
insomnia, that resembles ALMA in polysomnographic
appearance, rate (0.5–1.5 Hz), and association with
arousals and light sleep.15 However, both patients had
had recent head trauma (to which the author ascribed the
phenomenon), both had more prominent insomnia than
we found in our series, neither had PLMS or sleep apnea,
and neither showed the tremor in deep non-REM or
REM sleep. Alternation of movement from one leg to the
other was not mentioned, although the one published
polysomnographic fragment suggests alternation may
have occurred.15 The medications for each patient were
not listed, but administration of a tricyclic antidepressant
after head trauma is common. A subsequent study iden-
tified the phenomenon in 28 subjects among 375 studied:
355 were patients with sleep-related complaints and 20
were healthy control subjects.16 The authors called the
phenomenon “rhythmic feet movements while falling
asleep,” although the movements were sometimes ob-
served during light non-REM sleep or arousals from
REM sleep. These patients did not have head trauma,
most did not have insomnia, most did have sleep apnea,
several had PLMS or restless legs syndrome, but only 1
took an antidepressant. The leg movements “occurred
generally bilaterally but asynchronous in both legs.”
However, one figure clearly shows regular alternation
between left and right anterior tibialis EMG activations,
not commented on by the authors, but indistinguishable
from ALMA.
The cause of ALMA remains a mystery, but current
observations allow some speculation. The large majority
(75%) of our patients took antidepressants at the time of
the study. Antidepressants, including selective serotonin
FIG. 4. An alternating leg muscle activation (ALMA) sequence that coincided with similar muscle activations in the arms of this 57-year-old man.
Time scale and abbreviations as in Figures 1 and 3; led1-led2, red1-red2  left and right forearm extensor surface electromyogram; oral-nasal  oral
and nasal airflow monitored by thermocouple.
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reuptake inhibitors (SSRIs) and tricyclic compounds,
often worsen restless legs syndrome and PLMS, perhaps
because of increased serotonergic and associated de-
creased dopaminergic transmission.17–19 Bupropion dif-
fers from SSRIs in that it also inhibits dopamine re-
uptake; as might be expected, this compound has been
reported to reduce PLMS.20 Therefore, the observation
that 2 patients with ALMA took bupropion and no other
antidepressant argues against the idea that ALMA is due
to dopaminergic insufficiency or associated PLMS. The
possibility remains that increased serotonergic transmis-
sion facilitates ALMA, as bupropion also inhibits re-
uptake of this neurotransmitter.
The rate of ALMA approximates that of leg move-
ments during locomotion, the rhythm for which is me-
diated in large part by neuronal networks intrinsic to the
spinal cord.21 Isolated rat spinal cord preparations con-
tain these networks, or central pattern generators, that
produce lumbar ventral root output upon exposure to
serotonin.22 Output alternates side-to-side in a manner
and frequency that resembles ALMA.22 Serotonin recep-
tors exist at all spinal cord levels, and descending fibers
from brainstem serotonergic nuclei synapse on spinal
cord motorneurons, where they modulate and generally
facilitate motor output. If ALMA during sleep and arous-
als does reflect locomotor network activity, we speculate
that antidepressants might produce ALMA through en-
hancement of serotonergic transmission to central pattern
generators of the spinal cord. The PLMS recorded in
many of our patients could represent a related or else
similarly facilitated process.
Many potential links between our patients remain un-
explored, and we cannot rule out the possibility that one
of these explains the motor patterns we observed. How-
ever, the highly consistent finding of ALMA in repeated
recordings suggests the phenomenon was not an artifact,
a transient occurrence, or an acute result of untreated
sleep-disordered breathing. Whether the phenomenon
may carry any clinical import remains unknown, but its
occurrence at sleep-wake transitions raises the possibility
that further study might provide insight into mechanisms
of motor control during sleep.
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